Elaine Cruz Rosas

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Rheumatoid Arthritis

Inflammatory Response

Top Venues

Oxidative medicine and cellular longevity

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Inflammopharmacology

Fundação Oswaldo Cruz

Fundação Oswaldo Cruz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundação Oswaldo Cruz Jul 09 2002

Brazil

Researcher :: Department of Pharmacology /

Education History

Fundação Oswaldo Cruz Jan 05 2000 - Feb 16 2004

Brazil

PHD :: Department of Pharmacology/ Institute of Drug Technology

Publications

Luana Barbosa Correa, Tatiana Almeida Pádua, Paulo Vinicius Gil Alabarse, Elvira Maria Saraiva, Esdras Barbosa Garcia, Fabio Coelho Amendoeira, Fausto Klabund Ferraris, Sandra Yasuyo Fukada Alves, Elaine Cruz Rosas, Maria das Graças M O Henriques
Protective effect of methyl gallate on murine antigen-induced arthritis by inhibiting inflammatory process and bone erosion. Inflammopharmacology 30 (1) (2022)
Thais Morais de Brito, Fabio Coelho Amendoeira, Temistocles Barroso de Oliveira, Laís Higino Doro, Esdras Barbosa Garcia, Naína Monsores Felix da Silva, Amanda da Silva Chaves, Flavia Fontenelle Muylaert, Tatiana Almeida Pádua, Elaine Cruz Rosas, Maria das Graças M O Henriques, Valber da Silva Frutuoso, Simone Sacramento Valverde, Fausto Klabund Ferraris
Anti-Inflammatory Activity and Chemical Analysis of Different Fractions from Solidago chilensis Inflorescence. Oxidative medicine and cellular longevity 2021 (2021)
Luana Barbosa Correa, Leonardo Noboru Seito, Marília F Manchope, Waldiceu A Verri, Thiago Mattar Cunha, Maria G Henriques, Elaine Cruz Rosas
Methyl gallate attenuates inflammation induced by Toll-like receptor ligands by inhibiting MAPK and NF-Κb signaling pathways. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 69 (12) (2020)